Unlocking the unique catalysts of CoTiO3/BiVO4@MIL-Fe(53) for improving Cr(VI) reduction and tetracycline degradation.

Environmental contamination by hexavalent chromium (Cr(VI)) and antibiotic drug residues pose significant challenges to public health and ecosystems. This study investigates the application of CoTiO₃/BiVO₄@MIL-Fe(53) (CT/BV@Fe-MOF) for the reduction of Cr(VI) and degradation of tetracycline (TCL) under visible light. After grafting an iron-based metal–organic framework MIL-Fe(53) on a modified CoTiO₃/BiVO₄ composite, the photogenerated electrons could easily be transferred from CoTiO₃ to BiVO₄/Fe-MOF species via interfacial charge transfer. UV–vis diffuse reflectance spectroscopy showed that charge carriers were formed in response to visible light absorption. The effect of different operating parameters, including catalyst load, pH, initial Cr(VI), and TCL concentration, was systematically evaluated during the photocatalytic process. The CT/BV@Fe-MOF composite exhibited 98.7% reduction efficiency in Cr(VI) (50 ppm) and 97.5% degradation efficiency towards TCL (30 ppm) within 90 min, resulting in a greater efficiency than the pristine CoTiO₃, BiVO₄, and Fe-MOF materials. The CT/BV@Fe-MOF composite displayed excellent stability over six cycles, highlighting its potential for practical applications. In addition, the plausible degradation pathway of TCL was evaluated using LC-ESI/MS analysis, while the TEST program was utilized to investigate the toxicity of the products generated during the degradation process. [ABSTRACT FROM AUTHOR]